Published in Psychopharmacologia on July 23, 1975
5-Hydroxytryptamine and dopamine transport by rat and human blood platelets. Br J Pharmacol (1978) 0.82
Biochemical assessment of antidepressive drugs. Br J Clin Pharmacol (1980) 0.75
Platelet uptake of [14C]-5-hydroxytryptamine in "emotional" and "non-emotional" rats [proceedings]. Br J Pharmacol (1976) 0.75
Transport of dopamine by rat blood platelets [proceedings]. Br J Pharmacol (1977) 0.75
The two-period cross-over clinical trial. Br J Clin Pharmacol (1979) 13.21
Effects of atropine on heart-rate in healthy man. Lancet (1967) 5.10
Effect of homeopathic treatment on fibrositis (primary fibromyalgia) BMJ (1989) 5.00
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
The effects of a new beta-adrenoceptive receptor blocking drug on heart rate in man. Br J Pharmacol Chemother (1968) 3.95
Incidence of cancers of the larynx and lung near incinerators of waste solvents and oils in Great Britain. Lancet (1992) 3.71
Mucosal adherence of human enteropathogenic Escherichia coli. Lancet (1975) 3.54
The effect of propranolol on anxiety. Lancet (1966) 3.33
The Radical Cure of Inguinal Hernia in Children. Proc R Soc Med (1912) 3.29
Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol (1969) 3.25
Smoking behaviour can be predicted by neighbourhood deprivation measures. J Epidemiol Community Health (1995) 3.25
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol (2003) 3.14
Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med (1994) 2.80
Monitoring successive batches of British Comparative Thromboplastin. Br J Haematol (1973) 2.78
Differences in human alpha-, beta- and delta-globin gene expression in monkey kidney cells. Cell (1982) 2.78
Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 2.65
Follow-up of patients referred for termination of pregnancy. Lancet (1970) 2.54
Reference method for the one-stage prothrombin time test on hlman blood. International committee for standardization in hematology. Thromb Haemost (1976) 2.53
Sensitive method for the routine determination tricyclic antidepressants in plasma using a specific nitrogen detector. J Chromatogr (1975) 2.48
Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose, and its correlation with plasma concentration. Br J Clin Pharmacol (1976) 2.29
The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1999) 2.23
Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration. Br J Pharmacol (1971) 2.23
The severity of asthma in relation to beta agonist prescribing. N Z Med J (1991) 2.20
The Small Area Health Statistics Unit: a national facility for investigating health around point sources of environmental pollution in the United Kingdom. J Epidemiol Community Health (1992) 2.15
Talking about drugs - the role of the clinical pharmacologist. J R Soc Med (1982) 2.15
Cardiac and pulmonary effects of acebutolol. Lancet (1975) 2.12
The interactions of local guanethidine and sympathomimetic amines in the human eye. Arch Ophthalmol (1969) 2.09
Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet (1965) 2.09
Critical flicker frequency and centrally-acting drugs. Br J Ophthalmol (1968) 2.08
A simple method to measure drug effects on human sperm motility. Br J Clin Pharmacol (1981) 2.06
An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br J Clin Pharmacol (1975) 2.05
Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet (1966) 2.02
Relative potencies of sympathetic amines in human smooth muscle. Br J Pharmacol (1969) 1.98
Intravenous tyramine pressor response in depression. Lancet (1975) 1.98
Some central and peripheral effects of meclastine, a new antihistaminic drug, in man. J Clin Pharmacol New Drugs (1971) 1.94
Action of fenfluramine on isolated human smooth muscle. Lancet (1969) 1.94
The inhibitory action of procaine, (+)-propranolol and (+/-)-propranolol on human sperm motility: antagonism by caffeine. Br J Clin Pharmacol (1981) 1.88
Written information given to patients and families by palliative care units: a national survey. Lancet (2000) 1.88
Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol (1978) 1.86
The bioavailability of quinine. J Trop Med Hyg (1976) 1.80
Onchocerciasis in the Usambara mountains, Tanzania: the disease, its epidemiology and its relationship to ocular complications. Trans R Soc Trop Med Hyg (1966) 1.75
Class experiment in clinical pharmacology with benzilonium bromide, an anticholinergic drug. Eur J Clin Pharmacol (1974) 1.72
International trial of long-term dexfenfluramine in obesity. Lancet (1989) 1.70
A comparison of the effects of chlorphentermine, diethylpropion and phenmetrazine on critical flicker frequency. Br J Pharmacol Chemother (1967) 1.70
Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer (1996) 1.70
Prescription of benzodiazepines in a London teaching hospital. J R Soc Med (1990) 1.69
Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology (Berl) (1976) 1.68
Active conformation of the globin genes in uninduced and induced mouse erythroleukemia cells. Cell (1978) 1.64
Alpha receptor blockade by thymoxamine in the human eye. Clin Pharmacol Ther (1968) 1.60
Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun (2000) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Absorption of propranolol and practolol in Coeliac disease. Gut (1976) 1.55
Missed opportunities for the prevention of cardiovascular disease among British hypertensives in primary care. Br J Gen Pract (1996) 1.55
Bile duct injury during laparoscopic cholecystectomy: a report of the Standards Sub-committee of the Victorian State Committee of the Royal Australasian College of Surgeons. Aust N Z J Surg (1993) 1.53
The Treatment of a Denture, Swallowed and Impacted in the OEsophagus, by means of Killian's OEsophageal Tube. Proc R Soc Med (1909) 1.51
Explanation for potency of repeated oral doses of morphine? Lancet (1987) 1.47
Proceedings: Effect of fenfluramine and norfenfluramine on glucose uptake by the isolated rat diaphragm. Br J Pharmacol (1974) 1.46
A comparison of the effects of propranolol and practolol on forced expiratory volume and resting heart rate in normal subjects. Arch Int Pharmacodyn Ther (1971) 1.45
Intravenous treatment with rimiterol and salbutamol in asthma. Br Med J (1975) 1.45
Chlortenoxicam pharmacokinetics in young and elderly human volunteers. Postgrad Med J (1988) 1.45
Analgesic effects of oral flecainide. Lancet (1988) 1.41
HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. Cancer Res (2001) 1.41
A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. J Clin Pharmacol J New Drugs (1968) 1.40
Local formularies and good patient care. Br Med J (Clin Res Ed) (1984) 1.39
Sulfasalazine interference in total protein measurement on the Beckman CX7. Clin Chem (1993) 1.39
The narcotic equivalency index. World Health Forum (1989) 1.38
Effect of promethazine hydrochloride on hand-eye co-ordination. Nature (1966) 1.38
The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency. Psychopharmacologia (1976) 1.38
Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions. Postgrad Med J (1985) 1.38
Beta-adrenergic-receptor blockade with practolol in treatment of anxiety. Lancet (1972) 1.37
Aspartame pharmacokinetics - the effect of ageing. Age Ageing (1996) 1.37
Changes in gut flora after cephalexin treatment. Br Med J (1970) 1.37
Relative stability of alpha- and beta-globin messenger RNAs in homozygous beta+ thalassemia. Proc Natl Acad Sci U S A (1977) 1.36
Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels. Lancet (1984) 1.34
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33
Non-communicable disease mortality rates using the verbal autopsy in a cohort of middle aged and older populations in Beirut during wartime, 1983-93. J Epidemiol Community Health (2001) 1.33
Current status of clinical pharmacology in the United Kingdom. Clin Pharmacol Ther (1986) 1.32
Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine. Br J Clin Pharmacol (1983) 1.30
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. Br J Clin Pharmacol (1978) 1.29
Influence of disease on drug toxicity. Arch Toxicol Suppl (1984) 1.29
Plasma uptake of dopamine and 5-hydroxytryptamine and plasma-catecholamine levels in patients with Huntington's chorea. Lancet (1974) 1.27
Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet (1983) 1.26
Preliminary studies on the central effects of lorazepam, a new benzodiazepine. J Clin Pharmacol New Drugs (1972) 1.26
Stimulation of dopamine receptors (type 2) lowers human intraocular pressure. Br J Ophthalmol (1985) 1.26
Clinical pharmacology and general patient care in two teaching hospitals. J R Soc Med (1980) 1.25
Promethazine on hand-eye co-ordination and visual function. J Pharm Pharmacol (1971) 1.24
Beta-receptors in human isolated smooth muscle. Br J Pharmacol (1969) 1.24
Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. Br J Clin Pharmacol (1975) 1.23
D-Propranolol and anxiety. Lancet (1971) 1.23
Beta-adrenergic receptor blocking drugs in hyperthyroidism. Drugs (1974) 1.22
Fenfluramine and critical flicker frequency. J Pharm Pharmacol (1967) 1.21
Preliminary studies of a new bronchodilator (WG 253) in man. J Clin Pharmacol New Drugs (1971) 1.20
Proceedings: The influence of urine pH on the renal excretion of practolol and propranolol. Br J Pharmacol (1973) 1.20
Clinical pharmacology: function, organisation, and training. Lancet (1971) 1.19
Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs. Br J Clin Pharmacol (1982) 1.19
Comparison of propranolol and I.C.I. 50,172 on isoprenaline-induced increase in skin temperature in man. Br J Pharmacol (1969) 1.19